Plus Therapeutics (PSTV) FCF Payout Ratio (2015)
Plus Therapeutics (PSTV) reported FCF Payout Ratio of 0.0 for Q2 2015, up 95.71% quarter-over-quarter from 0.01 in Q1 2015.
Plus Therapeutics (PSTV) FCF Payout Ratio (2015) Analysis & Trends
Plus Therapeutics (PSTV) has 1 years of FCF Payout Ratio data on file, last reported at 0.0 in Q2 2015.
- FCF Payout Ratio for Q2 2015 came in at 0.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2016 was 0.0 (up 94.63% YoY), and the FY2015 annual result was 0.0, changed N/A from the prior year.
- FCF Payout Ratio climbed to 0.0 in Q2 2015 per PSTV's latest filing, from 0.01 in the prior quarter.
- Over five years, FCF Payout Ratio peaked at 0.0 in Q2 2015 and troughed at 0.01 in Q1 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Plus Therapeutics | 37.48 Mn | 22.37 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2015 | 0.00 |
| Mar 31, 2015 | -0.01 |